SMMT Latest Press Releases

-- December 5, 2025 --

Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 4:30 PM

-- November 7, 2025 --

Ivonescimab Plus Chemotherapy Demonstrates a Statistically Significant Benefit in Overall Survival with a Hazard Ratio of 0.74 in 2L+ Treatment of Patients with EGFRm NSCLC in HARMONi-A Study Conducted by Akeso in China Business Wire 9:00 AM

-- November 4, 2025 --

Summit Therapeutics to Present at Upcoming Investor Conferences Business Wire 7:00 AM

-- October 31, 2025 --

Overall Survival Data from HARMONi-A, Featuring Ivonescimab in Combination with Chemotherapy vs. Chemotherapy in 2L+ Treatment of Patients with EGFRm NSCLC in China, to be Showcased at SITC 2025 Business Wire 7:00 AM

-- October 22, 2025 --

Summit Therapeutics Raises $500 Million in Private Placement Business Wire 8:00 AM

-- October 20, 2025 --

Summit Therapeutics Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended September 30, 2025 Business Wire 6:45 AM

-- October 19, 2025 --

Ivonescimab with Chemotherapy Reduced the Risk of Disease Progression or Death by 40% Compared to Tislelizumab (PD-1 Inhibitor) Plus Chemotherapy in 1L Treatment of Patients with Squamous NSCLC in the HARMONi-6 Study Conducted by Akeso in China Business Wire 10:30 AM

-- October 18, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMT PRNewswire 10:00 AM

-- October 17, 2025 --

Summit Therapeutics Announces Expansion of Ivonescimab Global Phase III Development Program with HARMONi-GI3 Study in 1L Colorectal Cancer Business Wire 7:00 AM

-- October 15, 2025 --

Summit Therapeutics to Host ESMO Data Update & Third Quarter Earnings Call on October 20, 2025 Business Wire 7:00 AM

-- October 13, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMT PRNewswire 2:01 PM

-- October 8, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMT PRNewswire 5:45 PM

-- October 3, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMT PRNewswire 10:00 AM

-- September 28, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMT PRNewswire 10:01 AM

-- September 24, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMT Globe Newswire 4:38 PM

Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire 4:30 PM

HARMONi-6, Featuring Ivonescimab Combined with Chemotherapy vs. Tislelizumab Plus Chemotherapy in 1L Treatment of Patients with Squamous NSCLC in China, to be Showcased in Presidential Symposium at ESMO 2025 Business Wire 7:00 AM

-- September 23, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMT PRNewswire 10:00 AM

-- September 18, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMT PRNewswire 10:00 AM

-- September 16, 2025 --

Summit Therapeutics Inc. Investigated by the Portnoy Law Firm Globe Newswire 9:00 AM

-- September 14, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMT Globe Newswire 10:00 AM

-- September 13, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMT PRNewswire 10:00 AM

-- September 10, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMT Globe Newswire 2:51 PM

CORRECTION -- Summit Therapeutics Inc. Investigated by the Portnoy Law Firm Globe Newswire 12:43 AM

-- September 9, 2025 --

Summit Therapeutics Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. September 24, 2025 Deadline to file Lead Plaintiff Motion. Globe Newswire 3:35 PM

-- September 7, 2025 --

Ivonescimab Plus Chemotherapy Demonstrates Consistent Global Benefit: HARMONi Data Update Shows OS HR=0.78, Nominal P=0.0332 PRNewswire 6:08 AM

Longer-Term Follow-Up of Western Patients Showed Improving, Favorable Trend in Overall Survival in Global Phase III HARMONi Clinical Trial for Ivonescimab Plus Chemotherapy in 2L+ EGFRm NSCLC Business Wire 3:30 AM

-- September 3, 2025 --

Summit Therapeutics to Host Update Call at WCLC 2025 on September 8, 2025 Business Wire 7:00 AM

-- August 31, 2025 --

?? ?????, ???, ??? ? ??? ??? ??? 10?? (8? 25?~29?) Nabaparna Bhattacharya 6:55 PM

?? ?????, ???, ??? ? ??? ??? ??? 10?? (8? 25?~29?) Nabaparna Bhattacharya 6:54 PM

?? ?????, ???, ??? ???? ???(8? 25?~8? 29?) ??? ?? 10? ?? ?????: ??? ??????? ?? ???? ???? Nabaparna Bhattacharya 9:49 AM

Marvell Technology, eBay und DexCom gehren zu den Top 10 der groen Verlierer der letzten Woche (25. August - 29. August): Sind die anderen in Ihrem Portfolio? Nabaparna Bhattacharya 9:48 AM

Marvell Technology, eBay e DexCom sono tra i primi 10 grandi perdenti della scorsa settimana (25-29 agosto): sono presenti gli altri nel tuo portafoglio? Nabaparna Bhattacharya 9:48 AM

????? ??????? ?????? ???????? ?? ????? ?????? ?????? ???????? ?? ??????? ?????? (25 ????? - 29 ?????): ?? ?????? ?? ??????? Nabaparna Bhattacharya 9:48 AM

Marvell Technology, eBay y DexCom se encuentran entre los 10 principales perdedores de gran capitalizacin la semana pasada (del 25 al 29 de agosto): Estn los dems en su cartera? Nabaparna Bhattacharya 9:48 AM

Marvell Technology, eBay et DexCom font partie des 10 plus grandes baisses de la semaine dernire (25 aot - 29 aot) : Sont-ils galement dans votre portefeuille ? Nabaparna Bhattacharya 9:48 AM

??????????10????????Marvell Technology?eBay????DexCom????????(8?25??8?29?)???????????????????????? Nabaparna Bhattacharya 9:48 AM

??(8?25??8?29?),Marvell Technology?eBay?DexCom?????????????,?????????????? Nabaparna Bhattacharya 9:48 AM

Marvell Technology, eBay, And DexCom Are Among Top 10 Large Cap Losers Last Week (August 25-August 29): Are The Others In Your Portfolio? Nabaparna Bhattacharya 9:48 AM

-- August 14, 2025 --

Ivonescimab Data from Global Phase III HARMONi Study to be Showcased at Presidential Symposium at WCLC 2025 Business Wire 7:00 AM

-- August 11, 2025 --

SMMT Investors Have Opportunity to Lead Summit Therapeutics Inc. Securities Fraud Lawsuit with the Schall Law Firm Business Wire 8:07 PM

Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter Ended June 30, 2025 Business Wire 5:03 PM

-- July 27, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMT PRNewswire 10:00 AM

-- July 23, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMT Globe Newswire 10:00 AM

-- July 22, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMT PRNewswire 10:00 AM

-- July 18, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMT Globe Newswire 12:00 PM

-- July 17, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMT PRNewswire 10:00 AM

-- July 14, 2025 --

SMMT Investors Have Opportunity to Join Summit Therapeutics Inc. Fraud Investigation with the Schall Law Firm Business Wire 3:00 PM

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Summit Therapeutics Inc. - SMMT Globe Newswire 10:00 AM

-- July 12, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMT PRNewswire 10:00 AM

-- July 10, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMT Globe Newswire 9:00 AM

-- July 7, 2025 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Summit Therapeutics Inc. - SMMT PRNewswire 4:07 PM